Co-therapy with suboptimal doses of interleukin-12 and interferon-alpha promotes synergistic protection against herpes virus infection.
Rogerson
J A
JA
Department of Virology, Roche Research Centre, Herts, United Kingdom.
Pole
D S
DS
Carr
J A
JA
Roberts
N A
NA
Lamont
A G
AG
D000818:Animals; D004357:Drug Synergism; D006558:Herpes Genitalis / Q000276:immunology / Q000628:therapy*; D018258:Herpesvirus 2, Human; D007167:Immunotherapy; D016898:Interferon-alpha / Q000008:administration & dosage*; D018664:Interleukin-12 / Q000008:administration & dosage*; D051379:Mice; D008807:Mice, Inbred BALB C
D016898:Interferon-alpha; D018664:Interleukin-12